Orel Susan
Department of Radiology/Breast Imaging, Hospital of the University of Pennsylvania, 3400 Spruce St, Philadelphia, PA 19104, USA.
J Clin Oncol. 2008 Feb 10;26(5):703-11. doi: 10.1200/JCO.2007.14.3594.
During the last two decades, tremendous advances have been made in the performance and interpretation of breast magnetic resonance imaging (MRI) examinations. Technical requirements for optimal breast imaging including the requirement for a breast MRI biopsy system are now being defined as part of a voluntary American College of Radiology (ACR) breast MRI accreditation program. The ACR BI-RADS (Breast Imaging Reporting and Data System) lexicon for breast MRI has brought uniformity to the interpretation of breast MRI examinations. With these advances in imaging technique, interpretation guidelines, and increasing availability of MR-compatible breast biopsy systems, MRI of the breast is rapidly gaining popularity in clinical practice in both the diagnostic setting and, more recently, in the screening setting. The clinical indications for breast MRI, however, remain to be defined. There are clinical indications that have emerged where MRI, as an adjunct to mammography, seems to be the imaging study of choice. There are other indications, specifically breast cancer staging, in which MRI is being utilized with increasing frequency, but in which controversy persists.
在过去二十年中,乳腺磁共振成像(MRI)检查的性能和解读取得了巨大进展。包括乳腺MRI活检系统要求在内的最佳乳腺成像技术要求,目前正被确定为美国放射学会(ACR)乳腺MRI认证自愿计划的一部分。ACR乳腺MRI的BI-RADS(乳腺影像报告和数据系统)词典为乳腺MRI检查的解读带来了一致性。随着成像技术、解读指南的这些进展以及与MR兼容的乳腺活检系统的日益普及,乳腺MRI在临床实践中的诊断环境中,以及最近在筛查环境中迅速受到欢迎。然而,乳腺MRI的临床适应证仍有待确定。已经出现了一些临床适应证,其中MRI作为乳腺X线摄影的辅助手段,似乎是首选的影像学检查。还有其他适应证,特别是乳腺癌分期,MRI在其中的使用频率越来越高,但仍存在争议。